Marksans Pharma (NSE:MARKSANS) FFO


NSE:MARKSANS Marksans Pharma Ltd NSE:MARKSANS
90 GF Score
Price ₹261.20
GF Value ₹228.06
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Marksans Pharma FFO?

FFO (Funds from operations) only applies to REITs.

NSE:MARKSANS
90GF Score
Marksans Pharma Ltd NSE:MARKSANS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Marksans Pharma (NSE:MARKSANS) Overvalued in 2026?

Based on GuruFocus' analysis, Marksans Pharma stock appears to be overvalued. The current stock price of ₹261.20 is trading 14.5% above its estimated GF Value™ of ₹228.06. GuruFocus considers Marksans Pharma to be Modestly Overvalued.

Key valuation signals for NSE:MARKSANS:

  • FFO:
  • GF Value™: ₹228.06 vs. price of ₹261.20 (14.5% above fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the NSE:MARKSANS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Marksans Pharma Business Description

Other Exchanges 524404:India
Address Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.
90GF Score

Get the complete analysis for NSE:MARKSANS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹261.20
Price
₹228.06
GF Value